Singapore, Jan. 17 -- International research collaboration between the United States and Australia has revealed a promising new drug that could treat high-risk leukemia.

US based OncoTartis, Inc. and Australia based Children's Cancer Institute jointly announced the publication of two research manuscripts in a leading onco-hematological journal Leukemia, both devoted to the OncoTartis' clinical drug candidate OT-82.

A significant proportion of blood cancers in both adults and children remain resistant to current treatments and are often fatal. The results of studies conducted collaboratively by teams in Buffalo and Sydney open a new treatment opportunity for patients with currently incurable blood cancers by introducing a new drug candid...